JAK2 c.1611T>G ;(p.F537L)

Variant ID: 9-5070022-T-G

NM_004972.3(JAK2):c.1611T>G;(p.F537L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Pan-cancer whole-genome analyses of metastatic solid tumours.

Nature
Priestley, Peter P; Baber, Jonathan J; Lolkema, Martijn P MP; Steeghs, Neeltje N; de Bruijn, Ewart E; Shale, Charles C; Duyvesteyn, Korneel K; Haidari, Susan S; van Hoeck, Arne A; Onstenk, Wendy W; Roepman, Paul P; Voda, Mircea M; Bloemendal, Haiko J HJ; Tjan-Heijnen, Vivianne C G VCG; van Herpen, Carla M L CML; Labots, Mariette M; Witteveen, Petronella O PO; Smit, Egbert F EF; Sleijfer, Stefan S; Voest, Emile E EE; Cuppen, Edwin E
Publication Date: 2019-11

Variant appearance in text: JAK2: Phe537Leu
PubMed Link: 31645765
Variant Present in the following documents:
  • 41586_2019_1689_MOESM10_ESM.xlsx, sheet 1
View BVdb publication page



The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Journal Of Hematology & Oncology
Wu, Zhiyuan Z; Zhang, Xinju X; Xu, Xiao X; Chen, Yuming Y; Hu, Tingting T; Kang, Zhihua Z; Li, Shibao S; Wang, Hua H; Liu, Weiwei W; Ma, Xiaochao X; Guan, Ming M
Publication Date: 2014-07-15

Variant appearance in text: JAK2: F537L
PubMed Link: 25023898
Variant Present in the following documents:
  • Main text
  • s13045-014-0048-6.pdf
View BVdb publication page